Literature DB >> 6356291

Streptococcal toxins.

L W Wannamaker.   

Abstract

Few of the cellular components of group A streptococci appear to be directly toxic for animals or humans. Some preparations of M protein produce an immunotoxic effect on human platelets and neutrophils. Cell wall fragments produce a chronic multinodular inflammatory lesion of dermal connective tissue. The peptidoglycan component of cell walls has many of the biologic features of endotoxins. The exotoxins of group A streptococci include the erythrogenic toxins (pyrogenic exotoxins) and the cytolytic toxins (streptolysins S and O). The high prevalence of erythrogenic, toxin-producing strains is difficult to reconcile with the epidemiologic behavior of scarlet fever; the variations may be due to quantitative differences in toxin production or to a shift from the early scarlet fever-associated strains that produce A toxin to the currently prevalent strains that produce B and C toxins. Experiments with animals suggest that a positive Dick test and the rash of scarlet fever result not from a direct toxic effect but rather from enhancement by pyrogenic exotoxin(s) of acquired hypersensitivity to diverse streptococcal products. The mechanism of toxigenic phage conversion is not clear. The pyrogenic exotoxins are associated with the enhancement of endotoxin shock and a wide variety of other biologic properties. Streptolysin S is a nonantigenic polypeptide associated with various stabilizing carrier molecules. It lyses a wide range of mammalian cells, influences T lymphocyte functions, and is probably responsible for the leukotoxic property of group A streptococci. Rheumatic fever has been associated with a streptococcal outbreak due to a nonhemolytic (streptolysin S-negative) strain. Streptolysin O is an oxygen-labile (thiol-activated) cytolysin. It is inhibited by nonesterified cholesterol and binds to cholesterol in the membranes of mammalian cells and organelles, an interaction producing ring-like and C-shaped structures demonstrable by electron microscopy. Streptolysin O affects a number of leukocyte functions. It produces profound electrocardiographic changes in experimental animals and toxic effects on pulsating heart cells in tissue culture. The observation that rheumatic fever is not associated with infection of the skin due to group A streptococci has suggested that nonesterified cholesterol in the epidermis may inhibit a toxic effect of streptolysin O, an effect necessary for the development of rheumatic fever.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6356291     DOI: 10.1093/clinids/5.supplement_4.s723

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  12 in total

Review 1.  Spectrum of disease in bacteraemic patients during a Streptococcus pyogenes serotype M-1 epidemic in Norway in 1988.

Authors:  A Bucher; P R Martin; E A Høiby; A Halstensen; A Odegaard; K B Hellum; L Westlie; S Hallan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

2.  Do streptococci cause toxic shock?

Authors:  J A McGlashan
Journal:  BMJ       Date:  1990-12-15

3.  SpyA is a membrane-bound ADP-ribosyltransferase of Streptococcus pyogenes which modifies a streptococcal peptide, SpyB.

Authors:  Natalia Korotkova; Jessica S Hoff; Devon M Becker; John Kyle Heggen Quinn; Laura M Icenogle; Steve L Moseley
Journal:  Mol Microbiol       Date:  2012-01-30       Impact factor: 3.501

4.  Electron microscopic evaluation of a two-step theory of pore formation by streptolysin O.

Authors:  K Sekiya; H Danbara; K Yase; Y Futaesaku
Journal:  J Bacteriol       Date:  1996-12       Impact factor: 3.490

5.  A ring-shaped structure with a crown formed by streptolysin O on the erythrocyte membrane.

Authors:  K Sekiya; R Satoh; H Danbara; Y Futaesaku
Journal:  J Bacteriol       Date:  1993-09       Impact factor: 3.490

6.  Binding, oligomerization, and pore formation by streptolysin O in erythrocytes and fibroblast membranes: detection of nonlytic polymers.

Authors:  I Walev; M Palmer; A Valeva; U Weller; S Bhakdi
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

7.  In Situ Capture of Bacterial Toxins for Antivirulence Vaccination.

Authors:  Xiaoli Wei; Jie Gao; Fei Wang; Man Ying; Pavimol Angsantikul; Ashley V Kroll; Jiarong Zhou; Weiwei Gao; Weiyue Lu; Ronnie H Fang; Liangfang Zhang
Journal:  Adv Mater       Date:  2017-06-28       Impact factor: 30.849

8.  Combined contributions of streptolysin O and streptolysin S to virulence of serotype M5 Streptococcus pyogenes strain Manfredo.

Authors:  Michael C Fontaine; Jeong Jin Lee; Michael A Kehoe
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

9.  Group A beta-haemolytic streptococcus septicaemia: the toxic strep syndrome. Report of our cases developing septic shock and multiple organ failure.

Authors:  C Soravia; J A Romand; M Herrmann; J C Chevrolet; B Ricou; P M Suter
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

10.  Changes in the pattern of infection caused by Streptococcus pyogenes.

Authors:  E Gaworzewska; G Colman
Journal:  Epidemiol Infect       Date:  1988-04       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.